$4.51 (-3.01%)

Volume: 83.136k

Closed: May 26, 2023

Hollow Logo Score: -1.596
Capricor Therapeutics Stock
$4.51 (-3.01%)

Volume: 83.136k

Closed: May 26, 2023

Score Hollow Logo -1.596
NASDAQ:CAPR

Capricor Therapeutics Stock Price (Quote)

$4.51 ( -3.01% ) Friday, 26th May 2023

Range Low Price High Price Comment
30 days $3.70 $4.90 Friday, 26th May 2023 CAPR stock ended at $4.51. This is 3.01% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 7.04% from a day low at $4.41 to a day high of $4.72.
90 days $3.70 $5.22
52 weeks $3.30 $6.58

Historical Capricor Therapeutics prices

Date Open High Low Close Volume
2023-05-26 $4.46 $4.72 $4.41 $4.51 83 136
2023-05-25 $4.67 $4.75 $4.64 $4.65 33 063
2023-05-24 $4.72 $4.75 $4.61 $4.69 87 314
2023-05-23 $4.70 $4.90 $4.68 $4.74 61 873
2023-05-22 $4.51 $4.74 $4.50 $4.66 69 251
2023-05-19 $4.60 $4.72 $4.30 $4.50 112 056
2023-05-18 $4.34 $4.67 $4.34 $4.62 138 490
2023-05-17 $4.17 $4.38 $4.17 $4.35 29 672
2023-05-16 $4.08 $4.30 $4.02 $4.24 22 929
2023-05-15 $4.00 $4.20 $3.95 $4.19 40 385
2023-05-12 $4.08 $4.16 $3.94 $4.03 62 000
2023-05-11 $4.01 $4.15 $4.01 $4.11 29 212
2023-05-10 $4.15 $4.15 $4.04 $4.08 26 774
2023-05-09 $3.85 $4.17 $3.82 $4.03 89 634
2023-05-08 $3.95 $3.96 $3.79 $3.90 34 469
2023-05-05 $3.85 $3.99 $3.75 $3.92 77 336
2023-05-04 $3.81 $3.92 $3.77 $3.77 29 708
2023-05-03 $3.78 $3.95 $3.77 $3.84 37 617
2023-05-02 $3.92 $3.92 $3.70 $3.76 50 961
2023-05-01 $3.87 $4.01 $3.87 $3.91 38 713
2023-04-28 $3.88 $3.95 $3.85 $3.89 35 432
2023-04-27 $3.98 $3.99 $3.82 $3.88 53 629
2023-04-26 $3.96 $3.97 $3.86 $3.95 77 768
2023-04-25 $4.03 $4.06 $3.91 $3.93 67 930
2023-04-24 $4.13 $4.19 $3.92 $4.07 94 979
2023-04-21 $4.15 $4.19 $4.05 $4.12 60 015
2023-04-20 $4.20 $4.29 $4.13 $4.14 91 134
2023-04-19 $4.21 $4.29 $4.20 $4.23 35 955
2023-04-18 $4.29 $4.30 $4.20 $4.22 54 297
2023-04-17 $4.32 $4.39 $4.23 $4.29 101 845
2023-04-14 $4.30 $4.39 $4.21 $4.38 67 329
2023-04-13 $4.24 $4.29 $4.14 $4.25 41 828
2023-04-12 $4.24 $4.35 $4.24 $4.24 40 921
2023-04-11 $4.27 $4.32 $4.20 $4.29 66 488
2023-04-10 $4.29 $4.29 $4.15 $4.24 73 495
2023-04-06 $4.15 $4.25 $4.13 $4.18 41 525
2023-04-05 $4.11 $4.29 $4.07 $4.19 70 977
2023-04-04 $4.18 $4.19 $4.11 $4.17 30 305
2023-04-03 $4.22 $4.42 $4.17 $4.21 75 165
2023-03-31 $4.28 $4.32 $4.18 $4.22 17 992
2023-03-30 $4.15 $4.34 $4.15 $4.31 65 580
2023-03-29 $4.15 $4.30 $4.04 $4.17 108 494
2023-03-28 $4.10 $4.16 $4.01 $4.10 39 591
2023-03-27 $4.20 $4.27 $4.07 $4.11 58 051
2023-03-24 $4.13 $4.27 $4.06 $4.12 83 363
2023-03-23 $4.31 $4.40 $4.18 $4.19 49 705
2023-03-22 $4.50 $4.50 $4.28 $4.28 50 004
2023-03-21 $4.64 $4.64 $4.40 $4.40 55 170
2023-03-20 $4.45 $4.57 $4.32 $4.48 85 115
2023-03-17 $4.56 $4.57 $4.26 $4.34 128 065
Click to get the best stock tips daily for free!

About Capricor Therapeutics

Capricor Therapeutics Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for the treatment of patients with late-stage Duchenne muscular dystrophy (DMD); and CAP-1002, which is in Ph... CAPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT